Wayne Forrest

MRI
MRI suggests main reason for psychotic relapses
MR images have revealed decreased cortical thickness in people on antipsychotic drugs compared with those on placebo. But in both cases, their relapse back into psychosis may be due more to structural brain change than a lack of medication, according to a study published February 26 in JAMA Psychiatry.
February 26, 2020
2020 02 26 00 15 5307 Prescription Drugs Bottle 400
Molecular Imaging
Flortaucipir-PET, blood samples link brain injuries to CTE
Flortaucipir-PET and blood tests have correlated two key biomarkers of chronic traumatic encephalopathy (CTE) in military personnel who experienced traumatic brain injuries from blasts, according to a study published online on February 25 in Molecular Psychiatry.
February 25, 2020
2018 07 24 00 33 7964 Brain 400
MRI
MRI pinpoints shoulder stiffness from rotator cuff tears
Targeting joint capsule abnormalities in the shoulder on MRI scans can help determine which patients with rotator cuff tears will have preoperative shoulder stiffness, according to a study published February 19 in the American Journal of Roentgenology.
February 24, 2020
2020 02 24 22 13 4556 2020 02 25 Mri Shoulder A 20200224225834
MRI
MRI reveals brain changes from Parkinson's disease
An MRI technique known as quantitative susceptibility mapping reveals that patients with Parkinson's disease have increased iron deposition in the areas of the brain that handle cognition, memory, and motor function, according to a study published February 20 in the Journal of Neurology, Neurosurgery, and Psychiatry.
February 23, 2020
2020 02 21 22 35 4138 2020 02 24 3 D Mri Parkinsons 400
Breast
Could contrast mammo supplant CE-MRI for confirming breast cancer?
Contrast-enhanced (CE) mammography might be better suited than contrast-enhanced MRI for confirming some cases of suspicious breast cancer -- especially when radiation dose-reducing protocols are used, according to a study published February 14 in the Journal of Magnetic Resonance Imaging.
February 20, 2020
2016 10 05 17 45 45 493 Breast Cancer 400
MRI
AuntMinnie.com MRI Insider
February 18, 2020
Molecular Imaging
Amyloid PET results prompt adults to rethink their future
When PET scans reveal elevated amyloid levels in cognitively normal older adults, the prospect of possibly progressing to Alzheimer's disease prompts many of them to reconsider their future priorities.
February 17, 2020
2017 04 14 16 09 55 745 Amyloid Plaque Alzheimer 400
Molecular Imaging
FDG-PET/CT points to cervical cancer patient outcomes
Several indicators on pretreatment FDG-PET/CT scans can help predict overall survival in patients with locally advanced cervical cancer and para-aortic lymph node involvement. The markers could help clinicians steer patients toward more aggressive treatment, according to a February 7 study in Journal of Nuclear Medicine.
February 12, 2020
2017 09 14 23 05 1167 Cancer Cell 400
Molecular Imaging
PET shows cardiac meds may reduce beta-amyloid buildup
Patients who were on cardiovascular medications like cholesterol-lowering drugs seem to have lower levels of amyloid burden on PET scans, according to a study published February 7 in JAMA Network Open. The question is whether these findings indicate the individuals are at lower risk for Alzheimer's disease.
February 11, 2020
2017 04 14 16 09 55 745 Amyloid Plaque Alzheimer 400
MRI
Could a plant virus help create a new MRI contrast agent?
What's old is new for University of Texas at Dallas (UTD) researchers who are resurrecting an organic, biodegradable compound that someday might be the foundation for a nongadolinium-based MRI contrast agent, according to a preclinical study published online on February 5 in Chemical Science.
February 9, 2020
2020 02 07 21 15 8311 2020 02 10 Orca Mri Thumb
Previous Page
Page 7 of 239
Next Page
Top Stories
Ai Hand
Nuclear Medicine
LLMs rapidly evolving in nuclear medicine
Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.
2025 10 24 Jmri Said Fig2 Thumbnail
MRI
DWI with fat correction identifies liver scarring in MASLD patients
Emergency Sign
Ultrasound
Ghost scans problematic in POCUS trauma exams
Prostate Imaging
Molecular Imaging
PSMA-PET may require selective use to be cost-effective
Join Us!
Sponsor Content
Join Us!
More in Home
ASTRO: Trial suggests postoperative RT in high-risk bladder cancer
By Liz Carey
Moderate doses of radiation therapy (RT) after bladder removal surgery cut rates of new pelvic cancer, according to researchers.
September 30, 2025
Moscone Center Astro
ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression
By Will Morton
Two cycles of lutetium-177 PNT2002 before stereotactic body radiation therapy (SBRT) significantly improved progression-free survival.
September 29, 2025
Moscone Center Astro
ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer
By Liz Carey
Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.
September 29, 2025
Moscone Center Astro
NAPT survey results show promise for proton therapy adoption
By Amerigo Allegretto
Proton therapy continues to experience increased clinical use, but barriers to care continue to limit its potential.
September 29, 2025
Survey Form 400
ASTRO: Low-dose RT effective for treating knee osteoarthritis
By Amerigo Allegretto
Research presented at ASTRO 2025 showed the effectiveness of low-dose radiation therapy for treating knee osteoarthritis.
September 29, 2025
Moscone Center Astro
ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer
By Will Morton
Patients with a prostate tumor subtype known as luminal B had meaningful benefits from the addition of apalutamide to secondary radiotherapy.
September 29, 2025
Moscone Center Astro
ASTRO: Patient navigation key to mitigating RT treatment disparities
By Kate Madden Yee
"Patients are lost and need to be navigated," said presenter Christina Chapman, MD, of Baylor College of Medicine in Houston.
September 29, 2025
Moscone Center Astro
ASTRO: Radiotherapy offers opportunities beyond cancer treatment
By Kate Madden Yee
Radiotherapy isn't just for cancer treatment, according to talks at ASTRO 2025 in San Francisco.
September 28, 2025
Moscone Center Astro
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
New brain MRI technique could help identify Alzheimer's
By Kate Madden Yee
Researchers used 7-tesla MRI to demonstrate how microvessel pulses in the brain's deep white matter increase with age.
September 26, 2025
Mri Head
Scholarly activity low among residency program directors
By Amerigo Allegretto
Study results point toward program directors focusing on administrative responsibilities rather than scholarly activity.
September 26, 2025
Research Highlighter Res
3D DEXA shows value in patients with prostate cancer
By Will Morton
3D DEXA may be a practical and valuable tool for detecting structural bone changes in prostate cancer patients.
September 25, 2025
Dexa
Previous Page
Page 7 of 179
Next Page